Target intelligence / Profile preview

Macrophage activation pathway

Molecular classification
Other
01

Overview

The "Macrophage activation pathway" is not a single molecule or receptor but rather refers to the complex network of signaling events and metabolic changes that govern how macrophages respond to environmental cues. This process is often described as "macrophage polarization," where macrophages adopt different functional phenotypes—most notably the pro-inflammatory M1 and anti-inflammatory M2 states—in response to various stimuli such as cytokines, microbial products, or tissue signals[1][3][5]. The pathway involves numerous receptors and intracellular signaling molecules including Toll-like receptors (TLRs), interferon gamma receptor, transcription factors like NF-kB and STATs, and metabolic regulators. These pathways control gene expression programs that determine whether a macrophage will promote inflammation and pathogen killing (as in the M1 state) or support tissue repair and immune suppression (as in the M2 state)[3][5]. Because it describes a cellular process rather than a discrete molecular target, it cannot be directly targeted by drugs; instead, therapeutic strategies aim at modulating specific components within these pathways[4][6]. Key points: * The term does not refer to an individual protein or druggable target but encompasses multiple molecular players. * It is central to immune regulation in health and disease—including cancer progression/inhibition[2], chronic inflammation[5], infection control[3], autoimmune diseases[4], cardiovascular disease[6]. * Biomarkers for monitoring include surface proteins like CD80/CD86 for M1 phenotype. * No direct drugs interact with this "pathway" per se; interventions focus on upstream/downstream effectors. Conclusion: “Macrophage activation pathway” should not be treated as a canonical drug target entry. Instead, structured data should reference specific molecules within this process—such as TLR4 (“Toll-like receptor 4”), IFN-gamma receptor (“Interferon gamma receptor”), etc.—for accurate mapping of therapeutic targets.

Other names
Macrophage polarization pathwayMacrophage activationM1/M2 macrophage pathwayMacrophage functional reprogramming
02

Biological functions

Immune responseSignal transductionCell proliferationApoptosisInflammation regulation
03

Disease associations

CancerInflammationInfectionAutoimmune disease
04

Biomarkers

CD80 (M1 marker)CD86 (M1 marker)CIITA (M1 marker)MHC class II receptor (M1 marker)Cyclooxygenase 2/COX2 (M1 marker)Inducible nitric oxide synthase/iNOS (M1 marker)

Beyond the preview

Go deeper on Macrophage activation pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage activation pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call